Krensavage Asset Management, LLC Gilead Sciences, Inc. Transaction History

Krensavage Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$72.34 - $84.0 $8.52 Million - $9.89 Million	-117,755 Closed	0 $0
Q1 2020 May 18, 2020	SELL	$62.63 - $80.22 $257,158 - $329,383	-4,106 Reduced 3.37%	117,755 $8.8 Million
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $26.5 Million - $29.1 Million	-429,854 Reduced 77.91%	121,861 $7.92 Million
Q3 2019 Nov 15, 2019	BUY	$62.51 - $69.0 $29,879 - $32,982	478 Added 0.09%	551,715 $35 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $469,593 - $526,594	-7,590 Reduced 1.36%	551,237 $37.2 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.76 Million - $1.97 Million	28,128 Added 5.3%	558,827 $36.3 Million
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $63,203 - $82,476	-1,044 Reduced 0.2%	530,699 $33.2 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $489,950 - $639,347	-8,093 Reduced 1.5%	531,743 $36.6 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $482,351 - $534,051	6,767 Added 1.27%	539,836 $41.7 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $717,962 - $837,474	11,066 Added 2.12%	533,069 $37.8 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $3.2 Million - $3.9 Million	43,950 Added 9.19%	522,003 $39.4 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $3.05 Million - $3.58 Million	-42,871 Reduced 8.23%	478,053 $34.2 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $37.6 Million - $44.5 Million	520,924	520,924 $42.2 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Krensavage Asset Management, LLC with notifications on news.